Interleukin-10 Inhibits Tumor Necrosis Factor-alpha Production in Lipopolysaccharide-stimulated RAW 264.7 Cells Through Reduced MyD88 Expression
Overview
Microbiology
Authors
Affiliations
The mechanism of interleukin (IL)-10-mediated inhibition of tumor necrosis factor (TNF)-alpha production was studied by lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophage cells. IL-10 inhibited TNF-alpha production transiently at an early stage after LPS stimulation. IL-10 inhibited the activation of nuclear factor (NF)-kappaB, p38 and stress-activated protein kinase (SAPK) in LPS-stimulated RAW 264.7 cells. Although the level of MyD88 protein increased in response to LPS, IL-10 prevented the LPS-induced MyD88 augmentation. There was no significant difference in the MyD88 mRNA expression between the cells pretreated with or without IL-10 in response to LPS. Therefore, IL-10 was suggested to inhibit LPS-induced TNF-alpha production via reduced MyD88 expression.
Rafiei M, Shojaei A, Chau Y Drug Deliv. 2025; 32(1):2465909.
PMID: 40028722 PMC: 11878168. DOI: 10.1080/10717544.2025.2465909.
Solleiro-Villavicencio H, Mendez-Garcia L, Ocampo-Aguilera N, Baltazar-Perez I, Arreola-Miranda J, Aguayo-Guerrero J Medicina (Kaunas). 2024; 60(6).
PMID: 38929479 PMC: 11205754. DOI: 10.3390/medicina60060862.
Interleukin-10 signaling in somatosensory neurons controls CCL2 release and inflammatory response.
de Souza S, Rosario Claudio J, Sim J, Inyang K, Dagenais A, Monahan K Brain Behav Immun. 2023; 116:193-202.
PMID: 38081433 PMC: 10843623. DOI: 10.1016/j.bbi.2023.12.013.
Alexander A, Kelsey I, Forbes H, Miller-Jensen K Cell Rep. 2021; 36(12):109728.
PMID: 34551303 PMC: 8995750. DOI: 10.1016/j.celrep.2021.109728.
Sok M, Baker N, McClain C, Lim H, Turner T, Hymel L Biomaterials. 2020; 268:120475.
PMID: 33321293 PMC: 11129952. DOI: 10.1016/j.biomaterials.2020.120475.